TorsinA protein and neuropathology in early onset generalized dystonia with GAG deletion

Neurobiology of Disease

Volumn 12, Issue 1, 2003, Pages 11-24

  Rostasy, Kevin ^a,b   Augood, Sarah J ^c   Hewett, Jeffrey W ^c,d   Leung, Joanne Chung On ^c,d   Sasaki, Hikaru ^c   Ozelius, Laurie J ^e   Ramesh, Vijaya ^c   Standaert, David G ^c   Breakefield, Xandra O ^c,d   Hedreen, John C ^a,d  

^a TUFTS MEDICAL CENTER   (United States)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Dystonia; Human brain; Substantia nigra; Torsin

Indexed keywords

GENE PRODUCT; PROTEIN TORSINA; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CEREBELLUM; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; DNA STRAND BREAKAGE; DOPAMINERGIC NERVE CELL; FEMALE; GENE DELETION; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFANT; INFLAMMATION; MALE; NEOSTRIATUM; NEUROPATHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUBSTANTIA NIGRA; TISSUE DISTRIBUTION; TORSION DYSTONIA;

EID: 0037329443     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-9961(02)00010-4     Document Type: Article

References (48)

1. Asai D.J., Koonce M.P. The dynein heavy chain structure, mechanics and evolution . Trends Cell. Biol. 11:2001;196-202.
2. Augood S.J., Penney J.B., Friberg I., Breakefield X.O., Young A., Ozelius L.J., Standaert D.G. Expression of the early-onset torsion dystonia gene (DYT1) in human brain. Ann. Neurol. 43:1998;669-673.
3. Augood S.J., Martin D.M., Ozelius L.J., Breakefield X.O., Penney J.B.J., Standaert D.G. Distribution of the mRNAs encoding torsinA and torsinB in the adult human brain. Ann. Neurol. 46:1999;761-769.
4. Augood, S.J., Hollingsworth, Z., Albers, D.S., Yang, L., Leung, J.-C., Muller, B., Klein C., Breakefield, X.O., Standaert, D.G., 2002. Dopamine transmission in DYT1 dystonia: a biochemical and autoradiographical study. Neurology 58, in press.
5. Breakefield X.O., Kamm C., Hanson P.I. TorsinA movement at many levels . Neuron. 31:2001;9-12.
6. Bressman S.B., de Leon D., Brin M.F., Risch N., Burke R.E., Greene P.E., Shale M., Fahn S. Idiopathic dystonia among Ashkenazi Jews evidence for autosomal dominant inheritance . Ann. Neurol. 26:1989;612-620.
7. Bressman S.B., de Leon M.S., Kramer P.L., Ozelius L.J., Brin M.F., Greene P.E., Fahn S., Breakefield X.O., Risch N.J. Dystonia in Ashkenazi Jews clinical characterization of a founder mutation . Ann. Neurol. 36:1994;771-777.
8. Bressman S.B. Dystonia update. Clin. Neuropharmacol. 23:2000;239-251.
9. Burke R.E. The relative selectivity of anticholinergic drugs for the M1 and M2 muscarinic receptor subtypes. Mov. Disord. 1:1986;135-144.
10. Confalonieri F., Duguet M. A 200-amino acid ATPase module in search of a basic function. Bioessays. 17:1995;639-650.
11. Fahn S., Bressman S.B., Marsden C.D. Classification of dystonia. Fahn S., Marsden C.D., De Long M. Dystonia 3. 1998;1-10 Lippincott-Raven, Philadelphia.
12. Friedman J., Standaert D.G. Dystonia and its disorders. Neurol. Clin. 19:2001;681-705.
13. Greene P., Shale H., Fahn S. Analysis of open-label trial in torsion dystonia using high dosages of anticholinergics and other drugs. Mov. Disord. 2:1988;237-254.
14. Greene P., Kang U.J., Fahn S. Spread of symptoms in torsion dystonia. Mov. Disord. 10:1995;143-152.
15. Hedreen J.C., Zweig R.M., DeLong M.R., Whitehouse P.J., Price D.L. Primary dystonias a review of the pathology and suggestions for new directions of study . Adv. Neurol. 50:1988;123-132.
16. Hedreen J.C., Mucci L.A. Antigen retrieval for paraffin section immunocytochemistry with antibodies commonly used in studies of degenerative diseases. Soc. Neurosci. Abstr. 21:1995;1802.
17. Hewett J., Gonzalez-Agosti C., Slater D., Li S., Ziefer P., Bergeron D., Jacoby D.J., Ozelius L.J., Ramesh V., Breakefield X.O. Mutant torsinA, responsible for early onset torsion dystonia, forms membrane inclusions in culture neural cells. Hum. Mol. Genet. 9:2000;1403-1413.
18. Ichinose H., Ohye T., Takahashi E., Seki N., Hori T., Segawa M., Nomura Y., Endo K., Tanaka H., Tsuji S., Fujita K., Nagatsu T. Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene. Nature Genet. 8:1994;236-242.
19. Klein C., Friedman J., Bressman S., Vieregge P., Brin M.F., Pramstaller P.P., de Leon D., Hagenah J., Sieberer M., Fleet C., Kiely R., Xin W., Breakefield X.O., Ozelius L.J., Sims K.B. Genetic testing for early-onset torsion dystonia (DYT1) Introduction of a simple screening method, experiences from testing of a large patient cohort, and ethical aspects . Genet. Testing. 3:1999;323-328.
20. Konakova M., Huynh D.P., Yong W., Pulst S.M. Cellular distribution of torsinA and torsinB in normal human brain. Arch. Neurol. 58:2001;921-927.
21. Kunig G., Leenders K.L., Antonini A., Vontobel P., Weindl A., Meinck H.M. D2 receptor binding in dopa-responsive dystonia. Ann. Neurol. 44:1998;758-762.
22. Kustedjo K., Bracey M.H., Cravatt B.F. TorsinA and its torsion dystonia-associated mutant forms are lumenal glycoproteins that exhibit distinct subcellular localizations. J. Biol. Chem. 275:2000;27933-27939.
23. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage. Nature. 277:1970;680-685.
24. Loopuijt L.D., Villablanca J.R., Sharifi P. Soma size of substantia nigra neurons increases after a prenatal neocortical lesion in cats. Dev. Brain Res. 130:2001;143-147.
25. Louis D.N., von Deimling A., Seizinger B.R. A (CA)n dinucleotide repeat assay for evaluating loss of allelic heterozygosity in small and archival human brain tumor specimens. Am. J. Pathol. 141:1992;777-782.
26. Migheli A., Cavalla P., Marino S., Schiffer D. A study of apoptosis in normal and pathologic nervous tissue after in situ end-labeling of DNA strand breaks. J. Neuropathol. Exp. Neurol. 53:1994;606-616.
27. Neal J.W., Pearson R.C.A., Cole G., Powell T.P. Neuronal hypertrophy in the pars reticulata of the substantia nigra in Parkinson's disease. Neuropathol. Appl. Neurobiol. 17:1991;203-206.
28. Neuwald A.F., Aravind L., Spouge J.L., Koonin E.V. AAA+ A class of chaperone-like ATPases associated with the assembly, operation, and disassembly of protein complexes . Genome Res. 9:1999;27-43.
29. O'Farrell C., Hernandez D.G., Evey C., Singleton A.B., Cookson M.R. Normal localization of ΔF323-Y328 mutant torsinA in transfected human cells. Neurosci. Lett. 327:2002;75-78.
30. Ozelius L.J., Kramer P.L., Moskowitz C.B., Kwiatkowski D.J., Brin M.F., Bressman S.B., Schuback D.E., Falk C.T., Risch N., de Leon D., Burke R.E., Haines J., Gusella J.F., Fahn S., Breakefield X.O. Human gene for torsion dystonia is located on chromosome 9q32-q34. Neuron. 2:1989;1427-1434.
31. Ozelius L.J., Hewett J.W., Page C., Bressman S., Kramer P., Shalish C., de Leon D., Brin M., Raymond D., Corey D.P., Fahn S., Risch N., Buckler A., Gusella J.F., Breakefield X.O. The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein. Nature Genet. 17:1997;40-48.
32. Ozelius L.J., Hewett J., Page C.E., Bressman S.B., Kramer P.L., Shalish C., deLeon D., Brin M., Raymond D., Jacoby D., Penney J., Risch N.J., Fahn S., Gusella J.F., Breakefield X.O. The gene (DYT1) for early onset torsion dystonia encodes a novel protein related to the Clp protease/heat shock family. Fahn S., Marsden C.D., De Long M. Dystonia 3. 1998;93-105 Lippincott-Raven, Philadelphia.
33. Ozelius L.J., Page C.E., Klein C., Hewett J.W., Mineta M., Leung J., Shalish C., Bressman S.B., de Leon D., Brin M.F., Fahn S., Corey D.P., Breakefield X.O. The TORIA (DYT1) gene family and its role in early-onset torsion dystonia. Genomics. 62:1999;377-384.
34. Pearson R.C.A., Neal J.W., Powell T.P.S. Bilateral morphological changes in the substantia nigra of the rat following unilateral damage of the striatum. Brain Res. 400:1987;127-132.
35. Portera-Cailliau C., Hedreen J.C., Price D.L., Koliatsos V.E. Evidence for apoptotic cell death in Huntington disease and excitotoxic animal models. J. Neurosci. 15:1995;3775-3787.
36. Rajput A.H., Gibb W.R., Zhong X.H., Shannak K.S., Kish S., Chang L.G., Hornykiewiez O. Dopa-responsive dystonia pathological and biochemical observations in a case . Ann. Neurol. 35:1994;396-402.
37. Risch N., de Leon D., Ozelius L.J., Kramer P., Almasy L., Singer B., Fahn S., Breakefield X., Bressman S. Genetic analysis of idiopathic torsion dystonia in Ashkenazi Jews and their recent descent from a small founder population. Nature Genet. 9:1995;152-159.
38. Ross C.A. Intranuclear neuronal inclusions A common pathogenic mechanism for glutamine-repeat neurodegenerative diseases? Neuron. 19:1997;1147-1150.
39. Schirmer E.C., Glover J.R., Singer M.A., Lindquist S. HSP100/Clp proteins a common mechanism explains diverse functions . Trends Biochem. Sci. 21:1996;289-296.
40. Segawa M. Hereditary progressive dystonia with marked diurnal fluctuation. Brain Dev. 22:2000;S65-80.
41. Sharma N., Hewett J., Ozelius L.J., Ramesh V., McLean P.J., Breakefield X.O., Hyman B.T. A close association of torsinA and α-synuclein in Lewy bodies. Am. J. Pathol. 159:2001;339-344.
42. Shashidharan P., Kramer B.C., Walker R., Olanow C.W., Brin M.F. Immunohistochemical localization and distribution of torsinA in normal human and rat brain. Brain Res. 853:2000;197-206.
43. Shashidharan P., Good P.F., Hsu A., Perl D.P., Brin M.R., Olanow C.W. TorsinA accumulation in Lewy bodies in sporadic Parkinson's disease. Brain Res. 877:2000;379-381.
44. Trojanowski J.Q., Lee V.M. "Fatal attractions" of proteins. A comprehensive hypothetical mechanism underlying Alzheimer's disease and other neurodegenerative disorders. Ann. N.Y. Acad. Sci. 924:2000;62-67.
45. Walker R.H., Brin M.F., Sandu D., Gujjari P., Hof O.R., Olanow C.W., Shashidharan P. Distribution and immunohistochemical characterization of torsinA immunoreactivity in rat brain. Brain Res. 900:2001;348-354.
46. Walker R.H., Brin M.F., Sandu D., Good P.F., Shashidharan P. TorsinA immunoreactivity in brains of patients with DYT1 and non-DYT1 dystonia. Neurology. 58:2002;120-124.
47. Zeman W., Dyken P. Dystonia musculorum deformans clinical, genetic and pathoanatomical studies . Psychiatry Neurol. Neurochir. 10:1967;77-121.
48. Zweig R.M., Hedreen J.C., Jankel W., Casanova M.F., Whitehouse P.J., Price D.L. Pathology in brainstem regions of individuals with primary dystonia. Neurology. 38:1988;702-706.